Published in

Wiley, Angewandte Chemie, 24(126), p. 6240-6244

DOI: 10.1002/ange.201402750

Links

Tools

Export citation

Search in Google Scholar

A series of potent CREBBP bromodomain ligands reveals an induced-fit pocket stabilized by a cation-π interaction.

Journal article published in 2014 by Tp Rooney, Panagis Filippakopoulos, Oleg Fedorov, Sarah Picaud, Wa Cortopassi, Da Hay, Sarah Martin, Anthony Tumber, Cm Rogers, Martin Philpott, Minghua Wang, Al Thompson, Td Heightman, Dc Pryde, Andrew Cook and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

The benzoxazinone and dihydroquinoxalinone fragments were employed as novel acetyl lysine mimics in the development of CREBBP bromodomain ligands. While the benzoxazinone series showed low affinity for the CREBBP bromodomain, expansion of the dihydroquinoxalinone series resulted in the first potent inhibitors of a bromodomain outside the BET family. Structural and computational studies reveal that an internal hydrogen bond stabilizes the protein-bound conformation of the dihydroquinoxalinone series. The side chain of this series binds in an induced-fit pocket forming a cation-π interaction with R1173 of CREBBP. The most potent compound inhibits binding of CREBBP to chromatin in U2OS cells.